Dr. E.A.C. Wiemer

Wijzig persoonsdata

• breast
• cancer
• cell
• cells
• concentrations
• drug
• expression
• gene
• lung
• protein
• receptor
• resistance
• screening
• treatment

Werkzaam als

Publicaties

(de meest recente is bovenaan geplaatst)

MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation

A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

Editorial: The long and winding road to better cancer cell-specific therapies

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Alle publicaties

Afgesloten onderzoeksactiviteiten

(de meest recente activiteit is bovenaan geplaatst)
Projectleider	Role of miRNAs in DNA damage response: relevance for cancer and cancer therapy

Classificatie

D23120	Kanker
D23220	Inwendige geneeskunde